- 专利标题： T CELL MANUFACTURING COMPOSITIONS AND METHODS
-
申请号： PCT/US2018/059896申请日： 2018-11-08
-
公开(公告)号： WO2019094642A8公开(公告)日： 2019-05-16
- 发明人: VAN BUUREN, Marit M. , LENKALA, Divya Reddy , VAN DEN BERG, Joost Huibert , KOHLER, Jessica , GOLDSTEIN, Matthew , FRITSCH, Ed , DEBOER, Renate , SCHUMACHER, Ton , BAKKER, Noor
- 申请人： NEON THERAPEUTICS, INC. , STICHTING HET NEDERLANDS KANKER INSTITUUT- ANTONI VAN LEEUWENHOEK ZIEKENHUIS
- 申请人地址： 40 Erie Street, Suite 110 Cambridge, Massachusetts 02139 US
- 专利权人： NEON THERAPEUTICS, INC.,STICHTING HET NEDERLANDS KANKER INSTITUUT- ANTONI VAN LEEUWENHOEK ZIEKENHUIS
- 当前专利权人： NEON THERAPEUTICS, INC.,STICHTING HET NEDERLANDS KANKER INSTITUUT- ANTONI VAN LEEUWENHOEK ZIEKENHUIS
- 当前专利权人地址： 40 Erie Street, Suite 110 Cambridge, Massachusetts 02139 US
- 代理机构： MCANDREW, Christopher W.
- 优先权： US62/583,229 20171108; US62/588,590 20171120; US62/618,445 20180117; US62/737,625 20180927
- 主分类号： A61K39/00
- IPC分类号： A61K39/00 ; A61K35/15
摘要：
The generation of antigen specific T cells by controlled ex vivo induction or expansion can provide highly specific and beneficial T cell therapies. The present disclosure provides T cell manufacturing methods and therapeutic T cell compositions which can be used for treating subjects with cancer and other conditions, diseases and disorders personal antigen specific T cell therapy.
公开/授权文献
- WO2019094642A1 T CELL MANUFACTURING COMPOSITIONS AND METHODS 公开/授权日：2019-05-16
